Rankings
▼
Calendar
RGEN Q1 2021 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena
RGEN
Repligen Corporation
$7B
Q1 2021 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$143M
+87.7% YoY
Gross Profit
$83M
58.2% margin
Operating Income
$36M
25.5% margin
Net Income
$29M
20.6% margin
EPS (Diluted)
$0.52
QoQ Revenue Growth
+31.5%
Cash Flow
Operating Cash Flow
$9M
Free Cash Flow
$194,000
Stock-Based Comp.
$7M
Balance Sheet
Total Assets
$1.9B
Total Liabilities
$371M
Stockholders' Equity
$1.6B
Cash & Equivalents
$711M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$143M
$76M
+87.7%
Gross Profit
$83M
$44M
+88.4%
Operating Income
$36M
$12M
+205.6%
Net Income
$29M
$10M
+200.1%
Revenue Segments
Product
$143M
100%
Royalty
$100,000
0%
← FY 2021
All Quarters
Q2 2021 →